Recent Updates
Recently added Catalysts
BDX Positive Sentiment

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Key Takeaway: BD (Becton, Dickinson and Company) will announce its financial results for the first quarter of fiscal 2026 on February 9, 2026. The audio webcast will provide insights into the company's performance and operational strategy. A news release with summary financial information will be available prior to the call.
Price reaction · baseline $203.42 (2026-01-26 close) · hit pre-market · 5 other BDX headline(s) in the window, move may be shared
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is hosting a financial results webcast, indicating transparency.
  • The company is committed to advancing health care through innovation.
  • BD has a global presence and partnerships to tackle health challenges.

Full Press Release Details

FRANKLIN LAKES, N.J.,Jan. 27, 2026/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Monday, February 9, 2026 to discuss the Company's financial results for its first quarter of fiscal year 2026, which ended on December 31, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website atwww.bd.com/investors, and a replay will be made available shortly after the call at the same website. Prior to the call, the Company will issue a news release and related presentation materials that will include summary financial information for the quarter. The news release and related presentation materials will be made available atwww.bd.com/investors.

About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visitbd.comor connect with us on LinkedIn atwww.linkedin.com/company/bd1/, X (formerly Twitter)@BDandCoor Instagram@becton_dickinson.

Contacts:
Media: Investors:
Matt Marcus Shawn Bevec
VP, Public Relations SVP, Investor Relations
[email protected] [email protected]

Frequently Asked Questions

When will BD announce its financial results?

BD will announce its financial results on February 9, 2026.

How can I access the BD financial results webcast?

The webcast can be accessed at BD's investor relations website.

What will be discussed during the BD webcast?

The webcast will discuss BD's financial results and operational strategy.

Where can I find the financial summary information?

The financial summary will be available in a news release on BD's website.

Last updated: Jan 27, 2026